Skip to main content

Table 1 Baseline characteristics of incident dialysis patients with and without MPI screening

From: Coronary artery disease screening and prognosis in incident dialysis patients

  MPI screening  
  Yes No p
  n = 164 n = 60  
Age (years) 64 ± 12 66 ± 17 0.350
Male (%) 67 55 0.097
BMI (kg/m2) 22 ± 3 22 ± 3 0.170
Diabetes (%) 55 37 0.016
SBP (mmHg) 154 ± 23 147 ± 30 0.069
DBP (mmHg) 78 ± 16 72 ± 11 0.014
Ejection fraction (%) 67 ± 9 66 ± 9 0.403
Albumin (g/dL) 3.3 ± 0.5 3.3 ± 0.5 0.525
Hemoglobin (g/dL) 8.1 ± 1.5 8.4 ± 1.6 0.260
Total cholesterol (mg/dL) 175 ± 53 177 ± 55 0.828
Triglyceride (mg/dL) 123 ± 72 132 ± 61 0.378
HDL-C (mg/dL) 50 ± 17 46 ± 15 0.172
Creatinin (mg/dL) 9.8 ± 3.5 8.6 ± 3.9 0.037
eGFR (mL/min/1.73 m2) 5.0 ± 1.7 5.8 ± 2.3 0.007
cCa (mg/dL) 8.0 ± 1.0 8.2 ± 0.9 0.107
P (mg/dL) 6.2 ± 1.7 5.8 ± 1.6 0.082
iPTH (pg/mL) 338 ± 315 302 ± 170 0.396
CRP (mg/dL) (IQR) 0.1 0.15 0.154
Statin (%) 18 19 0.953
RAS inhibitor (%) 66 53 0.071
Beta blocker (%) 23 17 0.321
Coronary artery disease (%) 27 (16.5)   
CRT (%) 9 (5.5)   
  1. BMI body mass index, CRP c-reactive protein, CRT coronary revascularization therapy, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, HDL-C high-density lipoprotein cholesterol, RAS renin angiotensin system